Skip to main content
. Author manuscript; available in PMC: 2020 Mar 3.
Published in final edited form as: Am J Hematol. 2019 Aug 9;94(10):E275–E278. doi: 10.1002/ajh.25588

Figure 1. Correlation between measured GFR and estimated GFR (ml/min/1.73m2) in those without sickle cell trait (A) versus those with sickle cell trait (B) and Time to events for the adverse outcomes of CKD progression (C), ESKD alone (D), CVD (E), and death (F).

Figure 1.

Panels A-B depict scatter plots with lines of best fit. There was strong correlation between mGFR and eGFR in those without SCT (r = 0.78) and those with SCT (r= 0.84). In panels C-F, time to event for selected adverse outcomes by SCT status are depicted.

Note: log rank test p-values > 0.05 for all outcomes